Publications Repository

Publications Repository

Search 
  •   Home
  • ICR Divisions
  • Search
  • Home
  • ICR Divisions
  • Search
JavaScript is disabled for your browser. Some features of this site may not work without it.

Search

Show advanced filtersHide advanced filters

Filters

Use filters to refine the search results.

Now showing items 1-10 of 169

  • Sort Options:
  • Relevance
  • Issue date (newest)
  • Issue date (oldest)
  • Results Per Page:
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100
Thumbnail

Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers. 

Kuchenbaecker, KB; McGuffog, L; Barrowdale, D; Lee, A; Soucy, P; et al. (2017-07-01)
Background: Genome-wide association studies (GWAS) have identified 94 common single-nucleotide polymorphisms (SNPs) associated with breast cancer (BC) risk and 18 associated with ovarian cancer (OC) risk. Several of these ...
Thumbnail

Familial Risks and Mortality in Second Primary Cancers in Melanoma. 

Chattopadhyay, S; Hemminki, A; Försti, A; Sundquist, K; Sundquist, J; et al. (2018-10)
Background: Malignant melanoma (MM) patients are at increasing risk of developing second primary cancers (SPCs). We assessed mortality and risk of SPCs in MM patients with siblings or parents affected with same cancer ...
Thumbnail

A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer. 

Wang, V; Geybels, MS; Jordahl, KM; Gerke, T; Hamid, A; et al. (WILEY, 2021-07-01)
BACKGROUND: Inflammation and one of its mediators, NF-kappa B (NFκB), have been implicated in prostate cancer carcinogenesis. We assessed whether germline polymorphisms associated with NFκB are associated with the risk of ...
Thumbnail

Evaluating Germline Testing Panels in Southern African Males With Advanced Prostate Cancer. 

Gheybi, K; Jiang, J; Mutambirwa, SBA; Soh, PXY; Kote-Jarai, Z; et al. (Harborside Press, LLC, 2023-03-01)
BACKGROUND: Germline testing for prostate cancer is on the increase, with clinical implications for risk assessment, treatment, and management. Regardless of family history, NCCN recommends germline testing for patients ...
Thumbnail

Interim Results from the IMPACT Study: Evidence for prostate specific antigen screening in BRCA2 mutation Carriers 

Eeles, R (Elsevier, 2019-09-17)
Thumbnail

Combined Effect of a Polygenic Risk Score and Rare Genetic Variants on Prostate Cancer Risk. 

Darst, BF; Sheng, X; Eeles, RA; Kote-Jarai, Z; Conti, DV; et al.
Although prostate cancer is known to have a strong genetic basis and is influenced by both common and rare variants, the ability to investigate the combined effect of such genetic risk factors has been limited to date. We ...

Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry. 

Chen, F; Madduri, RK; Rodriguez, AA; Darst, BF; Chou, A; et al. (ELSEVIER, 2023-02-27)
BACKGROUND: Genetic factors play an important role in prostate cancer (PCa) susceptibility. OBJECTIVE: To discover common genetic variants contributing to the risk of PCa in men of African ancestry. DESIGN, SETTING, AND ...
Thumbnail

Dietary fat and early-onset prostate cancer risk. 

Lophatananon, A; Archer, J; Easton, D; Pocock, R; Dearnaley, D; et al. (CAMBRIDGE UNIV PRESS, 2010-05-01)
The UK incidence of prostate cancer has been increasing in men aged < 60 years. Migrant studies and global and secular variation in incidence suggest that modifiable factors, including a high-fat diet, may contribute to ...
Thumbnail

A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact. 

Macinnis, RJ; Antoniou, AC; Eeles, RA; Severi, G; Al Olama, AA; et al. (WILEY, 2011-07-18)
Genome wide association studies have identified several single nucleotide polymorphisms (SNPs) that are independently associated with small increments in risk of prostate cancer, opening up the possibility for using such ...
Thumbnail

Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14. 

Ruark, E; Seal, S; McDonald, H; Zhang, F; Elliot, A; et al. (NATURE PUBLISHING GROUP, 2013-06-01)
Testicular germ cell tumor (TGCT) is the most common cancer in young men and is notable for its high familial risks. So far, six loci associated with TGCT have been reported. From genome-wide association study (GWAS) ...
  • «
  • 1
  • 2
  • 3
  • 4
  • . . .
  • 17
  • »

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis communityBy issue dateAuthorsTitlesPublication Types

Discover

Author
Eeles, Rosalind (169)
Kote-Jarai, Zsofia (95)Saunders, Edward (19)Brook, Mark (15)Houlston, Richard (15)... View MoreSubjectHumans (120)Male (92)Prostatic Neoplasms (71)Genetic Predisposition to Disease (64)Polymorphism, Single Nucleotide (54)... View MoreDate Issued2020 - 2023 (55)2010 - 2019 (110)2001 - 2009 (3)Publication TypeJournal Article (169)
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.